During the past decade, Università Politecnica delle Marche, Clinica di Ematologia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università Politecnica delle Marche, Clinica di Ematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Università Politecnica delle Marche, Clinica di Ematologia" are "Classical Hodgkin Lymphoma" (1 trials), "DLBCL" (1 trials), "Hodgkin Lymphoma" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "T-Cell Lymphoma Refractory" (1 trials). Many other conditions were trialed in "Università Politecnica delle Marche, Clinica di Ematologia" in a lesser frequency.

Most popular intervention types in "Università Politecnica delle Marche, Clinica di Ematologia" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Venetoclax" (2 trials), "Bleomycin" (1 trials), "Dacarbazine" (1 trials), "Doxorubicin" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università Politecnica delle Marche, Clinica di Ematologia" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Università Politecnica delle Marche, Clinica di Ematologia". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Università Politecnica delle Marche, Clinica di Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Università Politecnica delle Marche, Clinica di Ematologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".